Ian Ganly is an Otolaryngologist in New York, New York. Dr. Ganly is rated as an Elite provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Thyroid Cancer, Papillary Thyroid Cancer, Tongue Cancer, Thyroidectomy, and Laryngectomy.

My career began at Beth Israel Medical Center/Continuum Health Partners in Manhattan, as a Physician-Scientist at that institution s newly established Institute for Head and Neck and Thyroid Cancer. I developed a basic science research laboratory, collaborating with senior investigators at the NYU School of Dental Medicine. My research was funded through a combination of national society and private foundation career development awards, and resulted in several publications, nationally recognized basic science research in head and neck oncology, and several national presentations and awards. In 2007, I was hired as Chief of the Division of Head and Neck Surgery at Long Island Jewish Medical Center (LIJ), in the early years of the (then) North Shore-LIJ Health System and North Shore-LIJ Cancer Institute. In this role I helped to establish one of the first fully integrated multidisciplinary oncology programs in our growing health system dedicated to the initial evaluation, care and survivorship of cancer patients, specifically those with head and neck tumors. The Head and Neck Oncology Program at Northwell has now evolved into one of regional as well as national renown, with the ability to deliver sophisticated multidisciplinary surgical and nonsurgical head and neck oncologic care at multiple sites throughout our network. Our clinical team also maintains a close collaboration with leading senior basic science investigators at Northwell's Feinstein Institute, focusing on HPV-associated oropharynx cancer. In 2014, I was appointed Northwell Health Cancer Institute s first Director of Surgical Oncology, and served in this position until early 2019. In the Spring of 2019, I was appointed Director of Operations of the Northwell Health Cancer Institute. In this capacity I serve as the liaison between the Institute, its members, and the various hospitals and outpatient cancer treatment facilities throughout the Northwell network where cancer care is delivered. In 2015, I was appointed Chair of LIJ s Commission on Cancer (CoC) recognized Cancer Committee. In this role I have worked with clinical and administrative colleagues to better integrate the inpatient cancer activities and resources of LIJ and North Shore University Hospital with those of our outpatient Cancer Institute facilities. I am presently involved in defining and solidifying Cancer Institute oversight over inpatient cancer related resources and activities, as well as CoC standards. My clinical leadership and program building accomplishments have been recognized both regionally as well as nationally with an American Cancer Society Doctor of Distinction Award (2017), an American Head and Neck Society Presidential Citation (2017), and a position on the Advanced Training Council of the American Head and Neck Society. Dr. Frank is rated as a Distinguished provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Tongue Cancer, Salivary Gland Tumors, Acinic Cell Carcinoma of Salivary Glands, Thyroidectomy, and Glossectomy.

Joph Steckel is an Urologist in Lake Success, New York. Dr. Steckel is rated as a Distinguished provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Nephrectomy, and Reconstructive Urology Surgery.

Sanford Dubner is an Otolaryngologist in Lake Success, New York. Dr. Dubner has been practicing medicine for over 44 years and is rated as a Distinguished provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Thyroid Nodule, Thyroid Cancer, Hyperparathyroidism, Thyroidectomy, and Thymectomy.

Vladimir Krichevsky is an Urologist in New Hyde Park, New York. Dr. Krichevsky is rated as a Distinguished provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Enlarged Prostate (BPH), Perirenal Abscess, Carbuncle, Boils, and Ureteroscopy.

Dr. Bhuvanesh Singh, a board-certified otolaryngologist and physician scientist with a distinction in research, specializes in head and neck surgery and reconstruction with a particular expertise in skin cancers. He joins Northwell after 27 years at Memorial Sloan-Kettering Cancer Center, where he served as the director of Laboratory of Epithelial Cancer Biology and founder and co-director of the Advanced Skin Cancer Management and Prevention Program. A recognized leader in his field, Dr. Singh has served on the AJCC staging and NCCN guideline committees. He has published over 300 peer-reviewed manuscripts, 30 book chapters, and several textbooks, including one of the leading textbooks in head and neck oncology. He has delivered over 500 lectures worldwide. Additionally, as an NIH-funded researcher, he developed a novel antineoplastic compound that is currently being codeveloped with a pharmaceutical company for human use.Dr. Singh has performed over 10,000 surgical procedures, the experience from which has allowed him to develop innovative surgical approaches that have significantly enhanced outcomes for the many common head and neck oncological and reconstructive procedures such as thyroidectomy, neck dissection, and oral cavity and scalp reconstruction. His combined expertise in cancer ablation and facial cosmetic and reconstructive surgery enables him to optimize cancer treatment while achieving excellent cosmetic and functional results for his patients. Dr. Singh values the doctor-patient relationship, treating every patient as he would a family member. He has developed evidence-based strategies to enhance this relationship, emphasizing effective communication and care among all team members. By prioritizing holistic care and collaborative approaches, Dr. Singh aims to ensure that each patient feels valued and supported throughout their treatment journey. Dr. Singh is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Acinic Cell Carcinoma of Salivary Glands, Tissue Biopsy, and Thyroidectomy.

Dev Kamdar is an Otolaryngologist in New Hyde Park, New York. Dr. Kamdar is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Mikulicz Disease, Gastrostomy, and Laryngectomy.

Lucio Pereira is an Otolaryngologist in New Hyde Park, New York. Dr. Pereira is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Oral Squamous Cell Carcinoma, Mikulicz Disease, Tongue Cancer, Gastrostomy, and Laryngectomy.

Louis Kavoussi, MD, MBA, Director of teleintervention at Northwell. He is a world-renowned urologic surgeon who brings more than 30 years of specialized expertise in minimally invasive urological surgery. His area of focus includes treating a wide range of urologic diseases, including kidney obstructions, renal stones and urologic cancer. At the forefront of innovation, Dr. Kavoussi pioneered several new surgical techniques, including the first minimally invasive approaches to kidney surgery for kidney cancer and kidney donation. He was also part of the team that performed the first laparoscopic prostate removal for cancer. In 1999, Dr. Kavoussi received a Smithsonian Computerworld Permanent Collection award for his work in developing telerounding, the starting point of telehealth medicine-to facilitate physician communication with hospitalized patients. Before joining Northwell in 2005 as chair of urology, Dr. Kavoussi completed his medical degree at the State University of New York at Buffalo. He obtained his urologic training at Washington University of St. Louis and, directly following residency, was named chief of urology at the Jewish Hospital of St. Louis. In 1991, he was appointed assistant professor at Harvard School of Medicine and director of endourology at the Brigham and Women's Hospital. In 1993, he joined the faculty of Johns Hopkins University School of Medicine, where he was vice chairman of urology and named a Patrick C. Walsh Distinguished Professor. Dr. Kavoussi values a team approach to care, and often collaborates with other specialists to create personalized and comprehensive treatment plans. His patients appreciate his easygoing personality and thoughtfulness. As the Waldbaum-Gardner Distinguished Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Kavoussi is passionate about training the next generation of surgeons. He has presented his work and given live surgical demonstrations at conferences around the world and has more than 500 academic publications. Dr. Kavoussi is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery.

Philip Perlman is an Otolaryngologist in Manhasset, New York. Dr. Perlman is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Ozena, Nonallergic Rhinopathy, Palatal Myoclonus, and Infant Hearing Loss.

Rajarsi Mandal is an Otolaryngologist in New Hyde Park, New York. Dr. Mandal is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Mikulicz Disease, Male Pattern Baldness, Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngectomy, and Thyroidectomy.

As Senior Vice President of the Urology Service Line, Chair of theSmith Institute for Urology, and Chair of Urology at the Zucker Schoolof Medicine at Hofstra/Northwell, Samir Taneja, MD will establish hisclinical practice at Lenox Hill Hospital and Long Island Jewish MedicalCenter focused on the surgical management of prostate cancerand renal tumors. He is an expert in urologic oncology, renowned fortransforming the field of prostate cancer diagnosis and treatmentby improving methods of prostate imaging, cancer detection, anddisease localization. Having performed thousands of robotic, ablative,laparoscopic and open surgical procedures, his specific clinical focushas been in improving prostate cancer patient outcomes throughpioneering techniques for focal ablative therapy, refining surgicaltechniques for robotic prostatectomy and partial nephrectomy,devising accelerated recovery pathways for robotic prostatectomy/partial nephrectomy, and providing muti-modal surgical approachesfor patients with high risk and recurrent prostate cancer. As leader ofthe department, he will strive to ensure individualized care of urologicdisease through state-of-the-art surgical approaches and multi-disciplinary care.Prior to joining Northwell, Dr Taneja was a faculty member of NYUGrossman School of Medicine for 29-years as a tenured professorof urology, radiology, and biomedical engineering. Most recently heserved as Director of the Division of Urologic Oncology and ViceChair in the Department of Urology at NYU Langone Health, as well asGenitourinary Program Leader in the Perlmutter Cancer Center.Dr. Taneja has conducted extensive clinical research on the use ofimaging in prostate cancer and is considered a pioneer in the use ofMRI to diagnose and localize prostate cancer and the emerging field ofprostate cancer focal therapy. He has authored more than 250 articles,30 book chapters, and six textbooks and monographs on urologiccancer and surgery. He is the editor of Taneja's Complications ofUrologic Surgery: Prevention and Diagnosis, one of the most widely readtextbooks in American Urology. Dr. Taneja is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy.

David M. Hoenig, MD, is a specialist in kidney stone treatment and minimally invasive surgery, including laparoscopic surgery. His specific clinical interests include all phases of kidney stone disease, from surgical treatment, to medical management, and to prevention. Dr. Hoenig completed medical school at the University of Rochester (Rochester, NY), and residency in Urology at Brown University (Providence, RI). He went on to one of the premier Laparoscopy and Endourology Fellowships in the country, under Dr. Ralph V. Clayman, one of the pioneers of minimally invasive urologic surgery, at Washington University (St. Louis, MO).After Fellowship training, Dr. Hoenig became a Clinical Instructor at the Medical College of Pennsylvania/Hahnemann under the auspices of Allegheny University, and was then recruited to Montefiore Medical Center/Albert Einstein College of Medicine to become the Director of Laparoscopy and Endourology and promoted to Assistant Professor. While at Montefiore, Dr. Hoenig assumed many administrative roles, as co-founder and co-Director of the Robotic, Laparoscopy, and Endourology Fellowship, Residency Program Director, and Practice Manager. After more than 14 years at Montefiore/Albert Einstein, he was recruited to North Shore- Long Island Jewish Hospital in 2013 with a promotion to Professor, and a shift of administrative roles to Chief of Urology Service at LIJ Hospital Campus. Dr. Hoenig's research interests are in all phases of minimally invasive urologic surgery, with particular attention to kidney stone disease, and both ablative and reconstructive minimally invasive renal surgery. His most recent publications explore the association of obesity with urological diseases, with new associations discovered between types of obesity and certain kidney stones. This research focus is a priority, given the national trend of increasing obesity, and will lead to exciting basic science exploration of these conditions.As a clinician, Dr. Hoenig's priority is treating patients with respect and empathy. He believes strongly in educating patients about their conditions, so as to equip them with the necessary information to make them a partner in their health care. Dr. Hoenig is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Kidney Stones, Medullary Sponge Kidney, Perirenal Abscess, Ureteroscopy, and Endoscopy.

Dr. Simon J Hall MD is a board certified urologist with Fellowship training in Urologic Oncology. His clinical interests include the diagnosis and treatment of Prostate, Bladder and Kidney cancers. He is especially interested in Active Surveillance of men with prostate cancer and men and women with incidentally found small renal masses and the creation of continent urinary reconstructions for patients who need to undergo cystectomy for Bladder cancer. Furthermore, Dr. Hall has a keen interest in treating patients with recurrent prostate cancer following definitive therapy. He believes that objective & balanced communication with the patient and family is the key to decision making and individualized care. Over the years Dr. Hall has been named as Best Doctor, both nationally and regionally, by organizations such as Castle Connolly, SuperDoctors and New York Magazine. Dr. Hall s research has focused of new therapies for prostate and bladder cancer; he has participated in numerous clinical trials, some of which generated data resulting in FDA approval of Sipleucel-T (Provenge) and enzulutamide (Xtandi). He oversees a laboratory investigating novel approaches to negating the Androgen Receptor, an important key driver of castration resistant prostate cancer. Decision making and improved methods of clinical care for patients with bladder and prostate cancer are important aspects of his research interests in collaboration with Dr. Michael Diefenbach, a behavioral scientist in the Departments of Urology & Medicine at NS-LIJ. He has authored or co-authored nearly 70 peer reviewed articles in Journals such as Journal of Urology, Urology, British Journal of Urology, Clinical Cancer Research and Science. Dr. Hall received his MD from the College of Physicians & Surgeons of Columbia University. He then completed two years of Surgery training at the Mount Sinai Medical Center followed by a four year residency in Urology at Boston University School of Medicine. This was followed by a 2 year fellowship in Urologic Oncology in the Scott Department of Urology at Baylor College of Medicine. Prior to joining the Smith Institute for Urology, he served on the faculty of Icahn School of Medicine at Mount Sinai for 18 years, holding various positions including Kyung Hyun Kim MD Chair of Urology and the Director of the Deane Prostate Health & Research Center. Dr. Hall is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Muscle Invasive Bladder Cancer, Prostate Cancer, Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery.

David Chan is an Urologist in Lake Success, New York. Dr. Chan is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Enlarged Prostate (BPH), Obstructive Uropathy, Boils, Ureteroscopy, and Prostatectomy.

Michael J. Schwartz, MD, is Chief of Urology at Long Island Jewish Medical Center and Director of Urology Services for Northwell Health's Central Region. Dr. Schwartz specializes in minimally invasive procedures to treat prostate cancer. He has vast experience in robotic-assisted radical prostatectomy, evolving surgical techniques over time to minimize treatment-related side effects. For qualifying prostate cancer patients, Dr. Schwartz also offers focal ablation therapies, using sophisticated image guidance and focal tissue ablation to eradicate prostate cancer with few side effects. He has additional expertise in urologic oncology and surgery to treat kidney, bladder, adrenal and testicular cancers. Becoming a doctor always felt natural to me, Dr. Schwartz says. I was always interested in helping others, and urology is a wonderful blend of both medical and surgical care, allowing for the development of long-term relationships with my patients. Dr. Schwartz earned his medical degree from Warren Alpert Medical School of Brown University and pursued his residency training in urology at New York-Presbyterian Hospital, Cornell. He received his fellowship training in advanced laparoscopic and endoscopic surgery at North Shore University Hospital and Long Island Jewish Medical Center. Dr. Schwartz values a team-based approach to care, working with radiologists, pathologists and medical oncologists to create individualized, evidence-based treatment plans. He also carefully listens to patients to meet their unique goals and preferences. In addition to treating prostate cancer, Dr. Schwartz is a pioneer in prostate cancer diagnosis. He was an early adopter of transperineal biopsy-which eliminates the infection risk associated with the prior transrectal method-and helped the Smith Institute of Urology transition to using that approach for all patients requiring prostate biopsy across Northwell Health. His research focuses on both diagnostics and treatment of prostate cancer, and he is involved with several clinical trials for focal therapy. He is a member of the American Urological Association and Society of Urologic Oncology. He is Associate Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. For Dr. Schwartz, one of the best parts of his job is getting to know his patients. I have the privilege of seeing their humanity, learning about their lives and discovering what's important to them, he says. Their experiences inspire me every day. Dr. Schwartz is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Enlarged Prostate (BPH), Reconstructive Urology Surgery, and Nephrectomy.

Assistant Professor of Radiation MedicineThe Center for Head & Neck OncologyNorthShore-LIJ-Stereotactic-Radiation-CenterHofstra North Shore- LIJ School of Medicine. Dr. Ghaly is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Laryngeal Cancer, Adenoid Cystic Carcinoma, Throat Cancer, Teratocarcinosarcoma, and Vertebroplasty.

Kenneth Scioscia is an Otolaryngologist in New Hyde Park, New York. Dr. Scioscia is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Infant Hearing Loss, Jones Syndrome, DFNB1, and Swallowing Difficulty.

Alec Vaezi is an Otolaryngologist in Mineola, New York. Dr. Vaezi is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Throat Cancer, Laryngeal Cancer, Acinic Cell Carcinoma of Salivary Glands, Tissue Biopsy, and Thyroidectomy.

Shervin Badkhshan is an Urologist in Garden City, New York. Dr. Badkhshan is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Urethral Stricture, Renal Oncocytoma, Chromophobe Renal Cell Carcinoma, Reconstructive Urology Surgery, and Prostatectomy.